Crocs (CROX) forecast a 9% to 11% decline in third quarter revenue on Thursday, as tariffs and a softer consumer…
Read More

Crocs (CROX) forecast a 9% to 11% decline in third quarter revenue on Thursday, as tariffs and a softer consumer…
Read More
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn, with…
Read More